Loading…
Loading…
BTEC (Principal Healthcare Innovators ETF) is no longer actively trading.
This usually means the fund has been liquidated, merged into another product, or its ticker has been retired. Every price, valuation, dividend, and analyst figure on this page is frozen at the last available trading session and reads as historical reference — not a current-day signal.
Under normal circumstances, the fund invests at least 80% of its net assets, plus any borrowings for investment purposes, in equity securities of companies in the healthcare sector. It invests significantly in early-stage companies within the healthcare equipment and supplies, pharmaceuticals, biotechnology, and life sciences industries that are not yet consistently profitable.
Is BTEC's expense ratio expensive, average, or a steal for its category?
Pro reveals the verdict on a 5-tier spectrum calibrated against ICI 2025 industry averages, with strategy-aware bands so the comparison is meaningful.
Sometimes it feels like it's Nvidia's world and we all just live in it. Why bother with anything else?
As rising rates are in the cards, value stocks are likely to take a center stage in the near term.
How a recession could impact health care stocks in 2023. As Covid continues, what it could mean for the health care sector.
If the ongoing pandemic has taught anything, it's the need for healthcare innovation. That's exactly what the Principal Healthcare Innovators ETF (BTEC) is all about.
In an effort to combat the coronavirus outbreak and accelerate the distribution process of extra doses in the United States, the FDA has approved the vaccine booster shots.